| Literature DB >> 27795936 |
Arpan De1, Guido Pasquantonio2, Loredana Cerroni2, Dezemona Petrelli3, Davide Lauro4, Marta Longhi2, Luca A Vitali1.
Abstract
Our study focuses on the antimicrobial susceptibility, genotypic and phenotypic heterogeneity, and serotype classification of the Streptococcus mutans isolated from type II diabetic patients (n = 25; age 42-68). Eighty-two percent of isolates were classified as serotype c. No serotype k was present. Macrorestriction analysis of genomic DNA of the isolates exhibited a clonal diversity that paralleled the phenotypic heterogeneity, which was also assessed in terms of biofilm forming ability. Isolates were susceptible to all the classes of antibiotics. In conclusion a great heterogeneity and no antimicrobial resistance were apparent in the considered S. mutans strains from diabetic patients.Entities:
Keywords: Antimicrobial susceptibility; Caries; PFGE; Plaque
Year: 2016 PMID: 27795936 PMCID: PMC5063833 DOI: 10.1186/s40064-016-3470-0
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Distribution of S. mutans isolates from diabetic patients according to the inhibition zone diameters (mm) exhibited by various antibiotics (EUCAST format)
| Antibiotic | Disk Content (μg) | Inhibition zone diameter (mm) | ||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | ||
| Vancomycin | 5 | 0 | 0 | 0 | 0 | 0 | 1 | 6 | 5 | 1 | 4 | 1* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Erythromycin | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 1 | 5 | 2 | 2 | 1 | 2* | 0 | 0 | 0 | 0 |
| Oxacillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 3 | 2 | 5* | 3 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Penicillin | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 3 | 4 | 4* | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Rifampicin | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 2 | 3 | 3 | 0 | 3 | 3* | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tetracycline | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 4 | 4 | 1 | 2 | 2* | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gentamicin | 10 | 0 | 0 | 0 | 2 | 1 | 2 | 3 | 1 | 3 | 4 | 0 | 0 | 2* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cefoxitin | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 6 | 4 | 3* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Linezolid | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 1 | 0 | 4 | 5* | 2 | 1 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Norfloxacin | 10 | 1 | 1 | 3 | 1 | 1 | 3 | 2 | 3 | 2 | 1* | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Clindamycin | 10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 1 | 6 | 5 | 0 | 0 | 3* | 1 |
| Levofloxacin | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 4 | 4 | 2 | 3 | 2* | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
* Zone diameter exhibited by the control strain UA159
Fig. 1Dendogram and schematic representation of PFGE pattern. Scale represents Pearson distance
Fig. 2Percentage of biofilm formation (bars) and cell aggregation (squares and dotted lines) among isolates. Error bar represents %Relative Standard deviation (RSD)